Skip to main content
. 2010 Mar 4;1(3):164–185. doi: 10.4161/gmic.1.3.12127

Table 1.

Effects of probiotic treatment in 7 randomized controlled trials in surgical patients with a high risk of post operative bacterial infections

Category Length of therapy (days) Treatment n Control group n Infection rate (probiotic vs. control)
Post-operative treatment
203 Major abdominal surgery (liver gastric, pancreas colon) 5 post 109L. plantarum 299 + oat fiber 30 109 heat killed L. plantarum 299 + oat fiber 30 10% vs. 10% (n.s.)
134 Liver transplantation 12 post 109L. plantarum 299 + oat fiber 31 109 heat killed L. plantarum 299 + oat fiber 32 13% vs. 34% (n.s.)
204 Liver transplantation 14 post Synbiotic 2000 (1010 of 4 different LAB and 4 fibers) 33 Fibers only 33 3% vs. 48% (p = <0.0001)
205 Hepatectomy 14 post 108B. breve, 108L. casei + enteral feeding 21 Enteral feeding 23 19% vs. 52% (p = 0.03)
Peri-operative treatment
206 PPPD 1 pre 8 post Synbiotic 2000 (1010 of 4 different LAB and 4 fibers) 40 Fibers only 40 12.5% vs. 40% (p = 0.01)
207 PPPD 3–15 pre 10 post E. faecalis, C. butyricum, Bacillus mesentericus 30 No treatment 34 23% vs. 53% (p = 0.02)
38 Hepatectomy 14 pre 14 post 1010B. breve, 1010L. casei (perioperatively) 41 1010B. breve, 1010L. casei (post operatively only) 40 12.1% vs. 30% (p = 0.049)

PPPD, pylorus-preserving pancreaticoduodenectomy; post, post-operatively; pre, pre-operatively; L, Lactobacillus; B, Bifidobacterium; E, Enterococcus; C, Clostridium. p values were calculated using Fisher's exact test.